OS-016 Week 48 top-line results from the phase 2b, multicenter, randomized, placebo-controlled IMPACT trial of pemvidutide in metabolic dysfunction-associated steatohepatitis

作者：Mazen Noureddin, Naim Alkhouri, Stephen A. Harrison, Rohit Loomba, Naga Chalasani, Shaheen Tomah, Julio Gutierrez, Dr John Suschak, M. Scot Roberts, Rachel Garner, Sarah Browne, Christophe Arbet‐Engels, M. SCOTT HARRIS · 发表于：Journal of Hepatology · 年份：2026 · DOI：10.1016/s0168-8278(26)00326-0 · 被引用次数：1 · 研究领域：Liver Disease Diagnosis and Treatment、Drug-Induced Hepatotoxicity and Protection、Pancreatitis Pathology and Treatment